NemaLife: Funding, Investors & Team (Sep 2026)
NemaLife's mission is to accelerate and de-risk R&D for companies in the food, nutraceutical, microbiome and pharma industries. In these industries, performing human-relevant high throughput biology and doing so with efficiency and speed has been a mutually exclusive affair. NemaLife has solved this major challenge by developing an AI-assisted microfluidics-based in vivo platform based on the microscopic worm C. elegans that has strong relevance for human biology. This 3R-compliant cruelty-free technology capable of testing a variety of compounds and their combinations is an alternative to expensive and time-consuming mouse models. We work with companies as their R&D partner, accelerating the value-chain from early-phase discovery to assessment of product potency and health claims. Our interdisciplinary team of engineers and biologists work with you to achieve your R&D objectives as well as co-create assets by developing custom biological readouts and new tech platforms. We have significant pre-clinical expertise in human wellness areas related to gut health, brain health, muscle health, metabolic health, cognitive health and healthy aging. We would be happy to share more details in a 15 min call.
NemaLife has raised $300k across 1 funding round on record, the most recent an undisclosed round of $300k announced in Oct 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NemaLife Company Profile and Key Stats
Latest funding round on record: Oct 2024.
NemaLife Funding Rounds
NemaLife Founders and Leadership Team
Contact details for the NemaLife team: 1 of 1 has an email address on file.
Start 14-day free trial →NemaLife Funding Compared to Other Biotechnology Startups
NemaLife's latest round of $300k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NemaLife in Biotechnology and Lubbock
Companies Similar to NemaLife
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
NemaLife Funding FAQs
What does NemaLife do?
NemaLife's mission is to accelerate and de-risk R&D for companies in the food, nutraceutical, microbiome and pharma industries. In these industries, performing human-relevant high throughput biology and doing so with efficiency and speed has been a mutually exclusive affair. NemaLife has solved this major challenge by developing an AI-assisted microfluidics-based in vivo platform based on the microscopic worm C. elegans that has strong relevance for human biology. This 3R-compliant cruelty-free technology capable of testing a variety of compounds and their combinations is an alternative to expensive and time-consuming mouse models. We work with companies as their R&D partner, accelerating the value-chain from early-phase discovery to assessment of product potency and health claims. Our interdisciplinary team of engineers and biologists work with you to achieve your R&D objectives as well as co-create assets by developing custom biological readouts and new tech platforms. We have significant pre-clinical expertise in human wellness areas related to gut health, brain health, muscle health, metabolic health, cognitive health and healthy aging. We would be happy to share more details in a 15 min call.
How much funding has NemaLife raised?
NemaLife has raised $300k across 1 round on record. The most recent is an undisclosed round of $300k announced in Oct 2024.
When did NemaLife last raise funding?
NemaLife's most recent funding round on record is an undisclosed round of $300k, announced in Oct 2024.
Who founded NemaLife?
FundedIQ lists Siva Vanapalli (Founder) at NemaLife.
Where is NemaLife headquartered?
NemaLife is based in Lubbock, Texas, United States.
How many employees does NemaLife have?
NemaLife is in the 11-50 employee band.
How does NemaLife's funding compare to other Biotechnology startups?
NemaLife's latest round of $300k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's NemaLife Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NemaLife is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.